Lookup NU author(s): Professor Quentin Anstee,
Professor Ann Daly,
Professor Chris Day
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Excess alcohol consumption with consequent alcoholic liver disease (ALD) and metabolic syndrome-related nonalcoholic fatty liver disease (NAFLD) are recognized as the most common causes of liver dysfunction worldwide. However, although the majority of heavy drinkers and individuals with obesity/insulin resistance will develop steatosis, only a minority progress to steatohepatitis, fibrosis, and cirrhosis. Both ALD and NAFLD are best considered complex disease traits where subtle interpatient genetic variations and environment interact to produce disease phenotype and determine disease progression. A decade after the sequencing of the human genome, the development of technologies to support the comprehensive study of genomic variation has begun to provide new insights into the modifier genes that contribute to this interpatient variation. Here we review the current status of the field with particular focus on advances from recent genome-wide association studies and their translation into a better mechanistic understanding of pathogenesis.
Author(s): Daly AK; Day CP; Anstee QM
Publication type: Review
Publication status: Published
Journal: Seminars in Liver Disease
Print publication date: 01/05/2011
ISSN (print): 0272-8087
ISSN (electronic): 1098-8971
Publisher: THIEME MEDICAL PUBL INC